AR094725A1 - Parvovirus 5a porcino, métodos de uso y vacuna - Google Patents
Parvovirus 5a porcino, métodos de uso y vacunaInfo
- Publication number
- AR094725A1 AR094725A1 ARP130104775A ARP130104775A AR094725A1 AR 094725 A1 AR094725 A1 AR 094725A1 AR P130104775 A ARP130104775 A AR P130104775A AR P130104775 A ARP130104775 A AR P130104775A AR 094725 A1 AR094725 A1 AR 094725A1
- Authority
- AR
- Argentina
- Prior art keywords
- seq
- acid sequence
- nucleic acid
- polypeptide
- nucleotide sequences
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000125945 Protoparvovirus Species 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 8
- 150000007523 nucleic acids Chemical group 0.000 abstract 5
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 241000702619 Porcine parvovirus Species 0.000 abstract 1
- 241000282887 Suidae Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 244000144980 herd Species 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Secuencias de nucleótidos, secuencias de proteínas, composiciones inmunogénicas, vacunas y métodos que se refieren a la obtención y al uso de un parvovirus porcino 5A (PPV5A) que infecta, entre otros, a los cerdos domésticos. Las composiciones y los métodos detectan infecciones causadas por los virus, controlan los cambios genéticos de las secuencias virales en animales y manadas salvajes y domésticas, y permiten la obtención y el uso de vacunas para proteger los animales contra la infección causada por el virus. Reivindicación 1: Un polinucleótido aislado, caracterizado porque comprende un polinucleótido a) que tiene la secuencia de ácidos nucleicos de SEQ ID Nº 1; b) que tiene una secuencia de ácidos nucleicos que codifica un polipéptido de SEQ ID Nº 2, SEQ ID Nº 3 o SEQ ID Nº 4; c) que tiene una secuencia de ácidos nucleicos que es 80% idéntica a SEQ ID Nº 1, que codifica un polipéptido que tiene una actividad eficaz desde el punto de vista inmunológico o biológico, de un polipéptido de SEQ ID Nº 2, SEQ ID Nº 3 o SEQ ID Nº 4; d) que es un fragmento de una secuencia de ácidos nucleicos de SEQ ID Nº 1, que comprende al menos 30 secuencias de nucleótidos contiguos de SEQ ID Nº 1, o e) que es un fragmento de la secuencia de ácidos nucleicos de SEQ ID Nº 1, que comprende al menos 30 secuencias de nucleótidos contiguos de SEQ ID Nº 1, y que codifica una actividad eficaz desde el punto de vista inmunológico, de una secuencia de aminoácidos de SEQ ID Nº 2, SEQ ID Nº 3 o SEQ ID Nº 4.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261738110P | 2012-12-17 | 2012-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR094725A1 true AR094725A1 (es) | 2015-08-26 |
Family
ID=50931160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130104775A AR094725A1 (es) | 2012-12-17 | 2013-12-16 | Parvovirus 5a porcino, métodos de uso y vacuna |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20140170180A1 (es) |
| EP (1) | EP2931741B1 (es) |
| AR (1) | AR094725A1 (es) |
| AU (1) | AU2014203571B2 (es) |
| CA (1) | CA2894708A1 (es) |
| CL (1) | CL2015001689A1 (es) |
| CO (1) | CO7461133A2 (es) |
| DK (1) | DK2931741T3 (es) |
| EA (1) | EA031278B1 (es) |
| ES (1) | ES2689515T3 (es) |
| MX (1) | MX2015007723A (es) |
| PH (1) | PH12015501378A1 (es) |
| SG (1) | SG11201504805PA (es) |
| TW (2) | TWI656213B (es) |
| UA (1) | UA117467C2 (es) |
| WO (1) | WO2014099669A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140170180A1 (en) | 2012-12-17 | 2014-06-19 | Boehringer Ingelheim Vetmedica, Inc. | Porcine parvovirus 5a, methods of use and vaccine |
| US20140234354A1 (en) | 2013-02-15 | 2014-08-21 | Boehringer Ingelheim Vetmedica, Inc. | Porcine parvovirus 5b, methods of use and vaccine |
| EP3132026B1 (en) * | 2014-04-17 | 2020-01-01 | Intervet International B.V. | Porcine parvovirus |
| WO2016210097A1 (en) * | 2015-06-23 | 2016-12-29 | The Trustees Of Columbia University In The City Of New York | Novel equine parvovirus and uses thereof |
| BR112019009133A2 (pt) | 2016-11-03 | 2019-07-16 | Boehringer Ingelheim Vetmedica Gmbh | vacina contra o parvovírus suíno |
| PL3534939T3 (pl) | 2016-11-03 | 2023-06-12 | Boehringer Ingelheim Vetmedica Gmbh | Szczepionka przeciw parwowirusowi świń i wirusowi zespołu rozrodczo-oddechowego świń oraz sposoby ich wytwarzania |
| KR102243368B1 (ko) * | 2019-04-17 | 2021-04-23 | 대한민국 | 돼지파보바이러스에 특이적인 단일클론항체 및 이의 용도 |
| CN111454969B (zh) * | 2019-09-02 | 2022-08-26 | 西北农林科技大学 | 带有双标签猪细小病毒全长感染性克隆制备方法及应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| EP0117767A1 (en) | 1983-01-07 | 1984-09-05 | Mgi Pharma, Inc. | Production of parvovirus subunit vaccines |
| US4708871A (en) | 1983-03-08 | 1987-11-24 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| US4567043A (en) | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
| US4567042A (en) | 1983-06-15 | 1986-01-28 | American Home Products Corporation | Inactivated canine coronavirus vaccine |
| FR2751227B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives |
| WO1998011244A2 (en) * | 1996-09-11 | 1998-03-19 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Aav4 vector and uses thereof |
| WO2002068698A2 (en) * | 2001-02-22 | 2002-09-06 | Xencor, Inc. | Use of nucleic acid libraries to create toxicological profiles |
| US10336797B2 (en) | 2009-11-23 | 2019-07-02 | Research Development Foundation | Recombinant filaggrin polypeptides for cell importation |
| US20140170180A1 (en) | 2012-12-17 | 2014-06-19 | Boehringer Ingelheim Vetmedica, Inc. | Porcine parvovirus 5a, methods of use and vaccine |
| US20140234354A1 (en) | 2013-02-15 | 2014-08-21 | Boehringer Ingelheim Vetmedica, Inc. | Porcine parvovirus 5b, methods of use and vaccine |
| EP3132026B1 (en) | 2014-04-17 | 2020-01-01 | Intervet International B.V. | Porcine parvovirus |
| RU2710041C2 (ru) | 2014-12-19 | 2019-12-24 | Интервет Интернэшнл Б.В. | Пестивирус |
| UA124140C2 (uk) | 2015-08-31 | 2021-07-28 | Бьорінгер Інгельхайм Ветмедіка Гмбх | Пестивірусна вакцина проти вродженого тремору поросят |
| BR112019009133A2 (pt) | 2016-11-03 | 2019-07-16 | Boehringer Ingelheim Vetmedica Gmbh | vacina contra o parvovírus suíno |
-
2013
- 2013-03-12 US US13/796,621 patent/US20140170180A1/en not_active Abandoned
- 2013-12-16 TW TW102146453A patent/TWI656213B/zh not_active IP Right Cessation
- 2013-12-16 TW TW107130755A patent/TW201920662A/zh unknown
- 2013-12-16 AR ARP130104775A patent/AR094725A1/es unknown
-
2014
- 2014-01-15 MX MX2015007723A patent/MX2015007723A/es active IP Right Grant
- 2014-01-15 EP EP13814791.3A patent/EP2931741B1/en not_active Revoked
- 2014-01-15 EA EA201500643A patent/EA031278B1/ru not_active IP Right Cessation
- 2014-01-15 AU AU2014203571A patent/AU2014203571B2/en not_active Ceased
- 2014-01-15 SG SG11201504805PA patent/SG11201504805PA/en unknown
- 2014-01-15 ES ES13814791.3T patent/ES2689515T3/es active Active
- 2014-01-15 CA CA2894708A patent/CA2894708A1/en not_active Abandoned
- 2014-01-15 UA UAA201506962A patent/UA117467C2/uk unknown
- 2014-01-15 DK DK13814791.3T patent/DK2931741T3/en active
- 2014-01-15 WO PCT/US2013/075059 patent/WO2014099669A1/en active Application Filing
-
2015
- 2015-05-15 US US14/713,700 patent/US9833507B2/en active Active
- 2015-06-16 CL CL2015001689A patent/CL2015001689A1/es unknown
- 2015-06-17 PH PH12015501378A patent/PH12015501378A1/en unknown
- 2015-07-17 CO CO15166795A patent/CO7461133A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014203571B2 (en) | 2017-09-28 |
| EP2931741B1 (en) | 2018-07-25 |
| TWI656213B (zh) | 2019-04-11 |
| PH12015501378B1 (en) | 2015-09-02 |
| CL2015001689A1 (es) | 2016-09-09 |
| US9833507B2 (en) | 2017-12-05 |
| PH12015501378A1 (en) | 2015-09-02 |
| ES2689515T3 (es) | 2018-11-14 |
| MX2015007723A (es) | 2015-09-23 |
| EA031278B1 (ru) | 2018-12-28 |
| TW201920662A (zh) | 2019-06-01 |
| US20150246113A1 (en) | 2015-09-03 |
| AU2014203571A1 (en) | 2015-06-11 |
| SG11201504805PA (en) | 2015-07-30 |
| CA2894708A1 (en) | 2014-06-26 |
| UA117467C2 (uk) | 2018-08-10 |
| DK2931741T3 (en) | 2018-10-22 |
| TW201437369A (zh) | 2014-10-01 |
| EA201500643A1 (ru) | 2015-12-30 |
| US20140170180A1 (en) | 2014-06-19 |
| EP2931741A1 (en) | 2015-10-21 |
| CO7461133A2 (es) | 2015-11-30 |
| WO2014099669A1 (en) | 2014-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR094725A1 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
| UY39060A (es) | Composiciones y métodos para prevenir y tratar la infección por coronavirus - vacunas sars-cov-2 | |
| ATE461710T1 (de) | Nipah-virus-impfstoffe | |
| EA200801756A1 (ru) | Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса | |
| DK1951296T4 (da) | Celleafledte viral vacciner med lave niveauer af restcelle-DNA | |
| NZ735684A (en) | Materials and methods for respiratory disease control in canines | |
| AR124928A2 (es) | Vacuna de herpesvirus-1 equino recombinante que contiene glicoproteína c mutada y usos de la misma | |
| BRPI0816134A2 (pt) | Herpesvírus, sequência de dna, vetor, célula, vírus, método para produção de partículas infecciosas, partículas infecciosas, vacina, uso de herpesvírus ou da sequência de dna ou do vetor ou das partículas infecciosas, e, método para o tratamento preventivo e/ou terapêutico de uma doença. | |
| BR112022016992A2 (pt) | Vacina com base em poxvírus recombinante contra ví-rus sars-cov-2 | |
| BR112012021650A2 (pt) | "parvovírus recombinante atenuado, vacina para a proteção de animais contra infecção com parvovírus, método para a obtenção de um parvovírus recombinante, e, uso de uma vacina." | |
| EA201500837A1 (ru) | Парвовирус свиней 5в, способы применения и вакцина | |
| AR053372A1 (es) | Proteinas inmunologicas de lawsonia intracellularis | |
| CL2021003211A1 (es) | Una cepa viva modificada, del virus del síndrome respiratorio y reproductivo porcino (prrs), vacuna que lo comprende y su uso para tratar el prrs tipo ii. (divisional solicitud no. 2123-2018) | |
| RU2015113826A (ru) | Выделение вируса, родственного парвовирусу-2 собак, от енота | |
| AR108014A1 (es) | Vacuna universal para enfermedades virales y método de vacunación | |
| PE20170429A1 (es) | Vacuna en vector recombinante de adenovirus aviar serotipo 9 | |
| MX2017014417A (es) | Vacunas contra el dengue. | |
| AR085800A1 (es) | Vacuna de rinitis equina | |
| MX2021015938A (es) | Virus para vacuna contra el síndrome respiratorio y reproductivo porcino. | |
| TW200801034A (en) | Novel sea lice vaccine | |
| EA201401044A1 (ru) | Модифицированный вирус болезни марека и вакцины на его основе | |
| RU2013107777A (ru) | Поливалентная вакцина против гриппа на основе гибридного белка | |
| RU2020100038A (ru) | Материалы и методы, используемые для лечения респираторных заболеваний у собак | |
| PE20130341A1 (es) | Vacuna de adn contra el virus de la fiebre amarilla | |
| AR106463A1 (es) | Vacunas de ácido nucleico para el virus varicela-zóster (vzv) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |